BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27596116)

  • 1. Layered nanohydroxyapatite as a novel nanocarrier for controlled delivery of 5-fluorouracil.
    Luo H; Ji D; Li C; Zhu Y; Xiong G; Wan Y
    Int J Pharm; 2016 Nov; 513(1-2):17-25. PubMed ID: 27596116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABRICATION AND IN VITRO EVALUATION OF 5-FLOROURACIL LOADED CHONDROITIN SULFATE-SODIUM ALGINATE MICROSPHERES FOR COLON SPECIFIC DELIVERY.
    Raza H; Ranjha NM; Razzaq R; Ansari M; Mahmood A; Rashid Z
    Acta Pol Pharm; 2016; 73(2):495-507. PubMed ID: 27180443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of 5-fluorouracil by incorporation into sodium carboxymethylcellulose sub-micron fibers.
    Cai X; Luan Y; Dong Q; Shao W; Li Z; Zhao Z
    Int J Pharm; 2011 Oct; 419(1-2):240-6. PubMed ID: 21782913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(9-Fluorenylmethoxycarbonyl)-L-Phenylalanine/nano-hydroxyapatite hybrid supramolecular hydrogels as drug delivery vehicles with antibacterial property and cytocompatibility.
    Li W; Hu X; Chen J; Wei Z; Song C; Huang R
    J Mater Sci Mater Med; 2020 Jul; 31(8):73. PubMed ID: 32729101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
    Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
    Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Anticancer Activity of 5-Fluorouracil Loaded in Cellulose Fibers Isolated from Rice Straw.
    Yusefi M; Shameli K; Jahangirian H; Teow SY; Umakoshi H; Saleh B; Rafiee-Moghaddam R; Webster TJ
    Int J Nanomedicine; 2020; 15():5417-5432. PubMed ID: 32801697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of targeted drug delivery system for fluorouracil using sulfadiazine as the carrier.
    Hu XG; Wang SM; Zhang QX; Cao MM; Lu Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1042-4. PubMed ID: 12433646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system.
    Tseng CL; Chen JC; Wu YC; Fang HW; Lin FH; Tang TP
    J Biomater Appl; 2015 Oct; 30(4):388-97. PubMed ID: 26069284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of different sized and porous hydroxyapatite nanorods without organic modifiers and their 5-fluorouracil release performance.
    Ji Y; Wang A; Wu G; Yin H; Liu S; Chen B; Liu F; Li X
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():14-23. PubMed ID: 26354235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release.
    Chandra VS; Baskar G; Suganthi RV; Elayaraja K; Joshy MI; Beaula WS; Mythili R; Venkatraman G; Kalkura SN
    ACS Appl Mater Interfaces; 2012 Mar; 4(3):1200-10. PubMed ID: 22316071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functionalized poly(amidoamine) nanocarrier-loading 5-fluorouracil: pH-responsive drug release and enhanced anticancer effect.
    Du L; Jin Y; Yang J; Wang S; Wang X
    Anticancer Drugs; 2013 Feb; 24(2):172-80. PubMed ID: 22990130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of 5-fluorouracil encapsulated in zeolites as drug delivery systems for in vitro models of colorectal carcinoma.
    Vilaça N; Amorim R; Machado AF; Parpot P; Pereira MF; Sardo M; Rocha J; Fonseca AM; Neves IC; Baltazar F
    Colloids Surf B Biointerfaces; 2013 Dec; 112():237-44. PubMed ID: 23988779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Supra-molecular assembly and magnetic targeted slow-release effect of "dextran-magnetic layered double hydroxide-fluorouracil" drug delivery system].
    Gou GJ; Liu YH; Sun Y; Huang J; Xue B; Dong LE
    Yao Xue Xue Bao; 2011 Nov; 46(11):1390-8. PubMed ID: 22260036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Effect of Toceranib and Nanohydroxyapatite as a Drug Delivery Platform-Physicochemical Properties and In Vitro Studies on Mastocytoma Cells.
    Sobierajska P; Serwotka-Suszczak A; Targonska S; Szymanski D; Marycz K; Wiglusz RJ
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Magnesium-Aluminum-Layered Double Hydroxide-Based Polyvinyl Alcohol Coated on Magnetite on the Preparation of Core-Shell Nanoparticles as a Drug Delivery Agent.
    Ebadi M; Buskaran K; Saifullah B; Fakurazi S; Hussein MZ
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
    Benito-Miguel M; Blanco MD; Gómez C
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU).
    Kevadiya BD; Patel TA; Jhala DD; Thumbar RP; Brahmbhatt H; Pandya MP; Rajkumar S; Jena PK; Joshi GV; Gadhia PK; Tripathi CB; Bajaj HC
    Eur J Pharm Biopharm; 2012 May; 81(1):91-101. PubMed ID: 22269936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil.
    Alanazi FK; Haq N; Radwan AA; Alsarra IA; Shakeel F
    Pharm Dev Technol; 2015 May; 20(3):266-70. PubMed ID: 24266739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the role of 5-fluorouracil in the polymerization of butylcyanoacrylate during the formation of nanoparticles.
    Simeonova M; Velichkova R; Ivanova G; Enchev V; Abrahams I
    J Drug Target; 2004 Jan; 12(1):49-56. PubMed ID: 15203911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.